Prevention of osteoporosis. Previous studies have shown that soy isoflavones
can prevent osteoporosis and reduce the symptoms of menopause. But
there is no scientific evidence to document their long-term safety and efficacy in preventing
osteoporosis. The main goal of $ 4. 5000000 project called prevention of osteoporosis
Use soy or OPUS whether isoflavones work, whether they are safe
for a long time and the optimal dosage. The secondary aim chat
results in clear terms and medical facilities
and consumers. Four healthy, in postmenopausal women will be enrolled at three sites in the U.S. two years of observation, a randomized, double-blind, placebo-controlled study >>. << One-third of women receiving placebo, one third will receive
isoflavones supplements to 80 mg / day, and the remaining third will be
to receive supplements of 120 mg isoflavones / day.
For security control, mammograms, and women-examination, pap smear, stool
Huayak tests and clinical chemistry blood will not. To control
efficiency, total body and regional bone content and density, and
as biochemical markers of bone will be measured. To determine the optimal dose
changes in bone measurements will be related to blood concentrations of isoflavones. Industrial partners are buy lasix online Acatris Holding BV, which provided SoyLife
isoflavones materials; EB Healthpharma BV, which is manufactured and packaged
isoflavones and placebo tablets; Swanson health products that provide
multivitamins, and Source Naturals, which provide calcium. Several states, several institutional investigation ensures that the results of research
represent postmenopausal women in the U.S. population. Increasing awareness of osteoporosis and translation and dissemination of scientific findings
, health professionals and consumers will improve the knowledge of how the
to prevent this common, costly, debilitating disease. . << >>